Sagimet Biosciences Inc. announced in connection with Mr. Thierry Chauche?s appointment as chief financial officer, he will serve as the company?s principal financial officer and principal accounting officer. On May 5, 2024, Joseph Oriti, the company?s interim Principal financial officer and interim principal accounting officer resigned in connection with Mr. Chauche?s appointment. Mr. Chauche, age 48, has over 20 years of financial and operational leadership experience in finance and healthcare companies.

He previously served as the Chief Financial Officer of Provention Bio Inc. (Provention). from December 2021 until it was acquired by Sanofi AG in April 2023. Prior to Provention Mr. Chauche served as the Vice President and Head of Strategic Financial Planning & Analysis at Alexion Pharmaceuticals Inc. from 2020 to 2021.

Prior to this, Mr. Chauche served in roles of increasing responsibility at Intercept Pharmaceuticals Inc. from 2017 to 2020, Novartis AG from 2007 to 2017, and Rothschild & Cie from 1999 to 2005. Mr. Chauche holds an M.S. in engineering from Ecole Des Ponts ParisTech and an MBA from the Wharton School of the University of Pennsylvania.